Home About Services Jurisdictions Insights FAQs Contact Us Client Login Terms & Conditions Privacy Policy Get a Quote →
Home Insights Using Patent Analytics To Prioritize Enforceable and Market-Relevant Assets
07/29/2026 12:54 PM

Using Patent Analytics To Prioritize Enforceable and Market-Relevant Assets

Introduction : Patents were primarily seen as legal monopolies, providing inventors a defined timeframe of exclusivity in return for revealing their invention. That understanding no longer fully explains how patents function in a globalised innovation economy. At present, patent rights serve as strategic economic resources that affect technology transfer, investment decisions, legal strategies, and industrial competitiveness. This change has created a corresponding need for analytical methods capable of identifying patents that are genuinely enforceable and commercially significant from those that simply exist on a register.

Patent analytics has developed into the field designed to address this demand, leveraging legal principles, litigation information, economic modelling, and more recently, artificial intelligence. This article examines the functioning of patent analytics in the legal frameworks of India, the United States, and the European Union, tracks the judicial progress that has influenced analytical methods, and explores the sector applications and policy discussions arising from the increasing dependence on data-driven management of intellectual property.

The Legal and Regulatory Foundations of Patent Analytics

No jurisdiction has a specific law that regulates patent analytics as a standalone subject. Rather, the field derives its legal foundation from intersecting areas of patent law, competition law, and commercial regulation, all of which dictate if a conferred right can truly be enforced and converted into profit. Since enforceability and commercial worth rely on court interpretations of validity, infringement, and remedies, analytical tools should be constructed based on the substantive law of each jurisdiction instead of a unified framework.

India: Balancing Private Rights and Public Interest

India's patent framework is governed by the Patents Act of 1970, revised after the country became a signatory to the Agreement on Trade-Related Aspects of Intellectual Property Rights. Adhering to the conditions of that agreement led to a notable rise in patent applications, foreign investment, and technology transfer; nevertheless, Indian courts have continued to see patent rights as dependent on public interest considerations instead of as unqualified private rights. Indian judicial practice has progressively examined the actual validity of a patent instead of merely accepting registration as evidence of enforceability, making analytical evaluation a practical requirement for businesses in the Indian market. Initiatives such as Startup India, Digital India, and the National Intellectual Property Rights Policy have bolstered this movement by motivating businesses to manage portfolios thoughtfully rather than accumulating patents randomly.

The United States: Litigation- and Commercialization-Driven Analytics

The United States created the most commercially focused patent system globally, leading to a correspondingly earlier and more extensive development of patent analytics compared to other regions. Patent assertion entities, technology firms, and investors depend on predictive models to evaluate portfolio robustness and litigation risk, a dependence amplified by the enormous scale of patent litigation costs in the U.S. Judicial cutbacks in the last ten years have significantly altered these models. The Supreme Court’s narrow interpretation of patent eligibility under Section 101 of the Patent Act revealed numerous software and business-method patents to invalidity disputes, compelling analytics providers to incorporate eligibility risk directly into portfolio assessments.

The European Union: Harmonization and Quality Assurance

The European perspective emphasizes legal certainty and technological quality more than the litigation-focused metrics prevalent in American practices. The opposition process of the European Patent Office puts granted patents through a strict administrative review, and the results of these proceedings are a valuable indicator of a patent's future enforceability. The establishment of the Unified Patent Court has added another analytical dimension, with companies now needing to assess litigation risk across multiple national systems that are consolidated under one adjudicative framework.

Patent Using

Judicial Decisions That Have Shaped Analytical Practice

Indian Jurisprudence : The Supreme Court made an important decision in the case of Novartis AG v. Union of India. This is the important case about patents in India in the last twenty years. The Court said that a new version of a medicine called imatinib mesylate could not be patented. This is because the new version was not very different from the version and did not work much better. The Court used Section 3(d) of the Patents Act to make this decision. Now people who make medicines have to prove that their new versions are really better before they can get a patent. Just getting a patent is not enough to make it valid.

Companies that analyze medicines now consider this when they look at patents in India. There was another case called F. Hoffmann-La Roche Ltd. V. Cipla Ltd. The Delhi High Court looked at a patent for a medicine that fights cancer. The Court had to decide if one company had copied another company's patent. The Court thought about what the patent meant and if it was fair to stop the other company from making the medicine. The Court said that companies have to think about if a patent's valid and if it is good for business. Now companies that analyze patents use computer programs to look at what a patent means. If it will be useful in court.

The phone company sector had its important cases. There were cases about essential patents with companies like Telefonaktiebolaget LM Ericsson and Micromax Informatics Ltd. The case of Telefonaktiebolaget LM Ericsson (Publ) v. Mercury Electronics & Anr is an example. These cases showed that an essential patent is valuable because it is necessary for technology and because companies use it fairly. It is not just valuable because it is new. Now companies that analyze patents look at how a patent's used and if it is fair not just if it is new.

​United States Jurisprudence : Alice Corporation Pty. Ltd. v. CLS Bank International altered the perspective on software and business-method patents by concluding that an abstract idea implemented on a conventional computer does not satisfy the eligibility requirements of Section 101 of the Patent Act. The choice unsettled significant parts of once-valuable software portfolios almost immediately and compelled analytics vendors to incorporate eligibility scoring into portfolio assessments as a standard element.

eBay Inc. v. MercExchange, L.L.C. eliminated the assumption that a determination of infringement grant a patentee an automatic right to injunctive relief, necessitating that courts utilize standard equitable criteria. The choice altered the enforcement approach to focus on negotiated licensing and necessitated analytics to assess the likelihood of securing an effective remedy, rather than merely the chance of demonstrating infringement.

TC Heartland LLC v. Kraft Foods Group Brands LLC narrowed the venues for filing patent infringement suits, reducing forum shopping and underscoring the importance of litigation analytics specific to jurisdiction.

​European Union Jurisprudence : The ruling by the Court of Justice of the European Union in Huawei Technologies Co. v. ZTE Corp. set forth the procedural steps that holders of standard-essential patents and implementers must adhere to before either side can pursue or contest an injunction. The decision continues to influence how analytics platforms evaluate licensing behavior, competition law risks, and market dominance threats in the telecom industry.

The Role of Artificial Intelligence in Predictive Patent Analytics

Artificial intelligence has emerged as the most revolutionary factor in modern patent analytics. Machine-learning systems can analyze vast amounts of patent documents, reveal technological connections that might escape manual examination, and produce probabilistic predictions of litigation results and commercialization prospects. The World Intellectual Property Organization has noted a dramatic increase in patent applications related to artificial intelligence over the last ten years, a phenomenon that has itself driven the need for more advanced

analytical framework. These systems can now do a lot of things like find out what has been done before, figure out how much something is worth, predict what will happen in court, map out the technology landscape, analyze competitors, find licensing opportunities and make portfolios better. When we use these systems people get worried about some things. They want to know how the algorithms work. If the data is biased. They are also worried that computers might start making decisions that should be made by humans especially when it comes to issues that affect everyone. So a lot of people think we should use a mix of intelligence and human judgment. The artificial intelligence can help us work faster and make predictions while humans are still in charge of making big decisions, about what the law means and what policies we should have Sector-Specific Applications of Patent Analytics.

Pharmaceuticals : Pharmaceutical development needs a lot of money. We are talking about billions of dollars to get one drug made and sold. This is why it is really important to look at patents. Companies use tools to check if a patent is good and if it can be enforced. They also try to figure out when other companies might start selling versions of the drug. They want to know if they might be forced to let other companies use their ideas.. They want to find ways to share technology with other companies. This is becoming more and more important with the rise of biosimilars and personalized medicine and the need for pharmaceutical development to be very careful about patents is growing. Pharmaceutical development is a process that requires careful planning and execution and pharmaceutical development companies must be very careful when it comes to patents.

Telecommunications and Standard-Essential Patents : Telecommunications companies have a lot of patents. They have some of the collections of patents that exist. Now that 5G is coming out and the equipment to support it is being installed Telecommunications firms are competing hard to control the patents.

There are tools that help Telecommunications firms find people who might want to pay to use their patents get better deals when they let others use their patents and figure out if they are at risk of getting sued or having problems with the law because of how they are competing with others.

Telecommunications companies can make a lot of money from their patents. In fact Telecommunications firms can make tens of billions of dollars every year from letting others use their essential patents.

​Venture Capital and Emerging Technologies : Investors are increasingly viewing patent quality as an indicator of the sustainability of a technology firm's competitive edge, especially in the biotechnology, software, and semiconductor industries. Analytics tools enable investors to evaluate the likelihood of enforcement, competitive stance, and long-term business viability prior to investing capital, and research indicates that startups with strategically designed portfolios secure funding more easily than similar companies lacking them.

Persistent Policy Challenges

The growing influence of patent analytics has sparked its share of debates. The fundamental patent databases continue to lack uniformity in quality, featuring inconsistent records and variations across jurisdictions that can skew predictive results. The increasing dependence on machine-learning models shaped by historical litigation data prompts worries about inherent bias and insufficient clarity regarding how Predictions are produced, sparking demands for increased accountability and human supervision, there exists a competitive aspect: companies equipped with advanced analytical systems might have an edge over smaller rivals and independent innovators, while the accumulation of predictive market data could potentially facilitate anti-competitive approaches to patent acquisition. Ultimately, especially in developing countries, decision-makers still consider the advantages of focusing on commercially significant patents against the potential danger of compromising access to healthcare, technology dissemination, and other public-interest goals.

Conclusion

The comparative analysis of India, the United States, and the European Union reveals significant differences in regulatory philosophy and enforcement structure regarding patent systems; however, these systems are increasingly aligning on a common understanding: the market value of a patent portfolio relies more on the strategic quality of its individual components than on their total quantity.

India's legal framework demonstrates that enforceability is intertwined with the actual technological merits and public-interest factors; the U.S. experience highlights how swiftly judicial adjustments can change the worth of an entire category of portfolios; and the European system showcases the analytical benefits of administrative quality-control processes like opposition proceedings and a cohesive legal adjudication structure. Artificial intelligence has advanced the complexity of predictive analytics in all three systems; however, it has not eliminated the requirement for legal judgment and is unlikely to do so considering the public-interest aspects that persist in patent enforcement

Author :- Shreya Goswami, in case of any query, contact us at Global Patent Filing or write back us via email at support@globalpatentfiling.com.

Endnotes

  1. Agreement on Trade-Related Aspects of Intellectual Property Rights art. 27, Apr. 15, 1994, 1869 U.N.T.S. 299; Patents Act, No. 39 of 1970, India Code (as amended by the Patents (Amendment) Acts of 1999, 2002, and 2005).
  2. Ashish Bharadwaj & Vishwas H. Devaiah, Pharmaceutical Patent Jurisprudence in India, 56 J. Indian L. Inst. 125 (2014).
  3. NITI Aayog, India Innovation Index Report (Gov't of India 2024).
  4. Robert P. Merges & John F. Duffy, Patent Law and Policy: Cases and Materials (8th ed. 2021).
  5. U.S. Patent & Trademark Office, Performance and Accountability Report 2025 (2025).
  6. 35 U.S.C. §§ 101–103, 112 (2018); Alice Corp. Pty. Ltd. v. CLS Bank Int'l, 573 U.S. 208 (2014).
  7. Convention on the Grant of European Patents (European Patent Convention), Oct. 5, 1973, 1065 U.N.T.S. 199.
  8. European Patent Office, Patent Index Report 2024 (2024).
  9. Organisation for Econ. Co-operation & Dev., Intellectual Property and Economic Growth Report (2023).
  10. Novartis AG v. Union of India, (2013) 6 S.C.C. 1; AIR 2013 SC 1311 (India).
  11. F. Hoffmann-La Roche Ltd. v. Cipla Ltd., (2015) 225 Delhi L.T. 391, 2015 SCC OnLine Del 13619, (2016) 65 P.T.C. 1 (Del.) (India).
  12. Telefonaktiebolaget LM Ericsson (Publ) v. Mercury Electronics & Anr., CS(OS) No. 442 of 2013 (Del. H.C.) (suit naming Micromax Informatics Ltd. as Defendant No. 2); Telefonaktiebolaget LM Ericsson (Publ) v. Intex Techs. (India) Ltd., CS(OS) No. 1045 of 2014, I.A. No. 6735 of 2014 (Del. H.C. Mar. 13, 2015) (India).
  13. Alice Corp. Pty. Ltd. v. CLS Bank Int'l, 573 U.S. 208 (2014).
  14. eBay Inc. v. MercExchange, L.L.C., 547 U.S. 388 (2006).
  15. TC Heartland LLC v. Kraft Foods Grp. Brands LLC, 581 U.S. 258, 137 S. Ct. 1514 (2017).
  16. Huawei Techs. Co. v. ZTE Corp., Case C-170/13, ECLI:EU:C:2015:477 (July 16, 2015).
  17. World Intellectual Prop. Org., Generative Artificial Intelligence Patent Landscape Report (2024).
  18. World Intellectual Prop. Org., Patent Analytics Handbook (2022).
  19. Bronwyn H. Hall, Adam B. Jaffe & Manuel Trajtenberg, Market Value and Patent Citations, 36 RAND J. Econ. 16 (2005).
  20. Dietmar Harhoff, Francis Narin, F.M. Scherer & Katrin Vopel, Citation Frequency and the Value of Patented Inventions, 81 Rev. Econ. & Stat. 511 (1999).
  21. Alfonso Gambardella, Dietmar Harhoff & Bart Verspagen, The Value of European Patents, 39 Eur. Mgmt. Rev. 69 (2008).
  22. William M. Landes & Richard A. Posner, The Economic Structure of Intellectual Property Law (2003).
  23. World Intellectual Prop. Org., World Intellectual Property Indicators 2025 (2025).
← Back to All Insights